Baricitinib
-
Catalog number2842-10
-
PricePlease ask
-
Size10 mg
-
-
Alternative_name2-[1-Ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile; INCB 028050;LY 3009104;INCB028050;LY3009104;LY-3009104;INCB-028050
-
DescriptionBaricitinib is a selective JAK1 and JAK2 inhibitor with IC₅₀ values of 5.9 nM and 5.7 nM, respectively. Baricitinib is ~70 and ~10-fold selective versus JAK3 and Tyk2, with no inhibition to c-Met and Chk2.
-
CAS Number1187594-09-7
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₆H₁₇N₇O₂S
-
Molecular Weight371.42
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>50 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent and selective JAK1 and JAK2 inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID44205240
-
SMILESCCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
-
InChiInChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
-
InChi KeyXUZMWHLSFXCVMG-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameBaricitinib
-
Alternative nameBaricitinib
-